scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0091-6749(97)70279-3 |
P698 | PubMed publication ID | 9438492 |
P2093 | author name string | M Hingorani | |
S L Lightman | |||
R J Buckley | |||
V L Calder | |||
D P Metz | |||
P433 | issue | 6 Pt 1 | |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 817-824 | |
P577 | publication date | 1997-12-01 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | T-cell cytokines in chronic allergic eye disease | |
P478 | volume | 100 |
Q57693368 | Activation des voies TH1/TH2 détectée par l′expression de CCR4 et CCR5 sur la surface oculaire de patients glaucomateux traités au long cours |
Q84135372 | Allergic conjunctivitis and nasal allergy |
Q34249329 | Allergic ocular disease. A review of pathophysiology and clinical presentations |
Q83969778 | Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis |
Q35790962 | Basic science and pathophysiology of ocular allergy |
Q37697882 | Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy |
Q37782084 | Clinical Review: Topical Ophthalmic Use of Cyclosporin A |
Q33253499 | Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles. |
Q36146027 | Curcumin suppresses ovalbumin-induced allergic conjunctivitis |
Q40252701 | Cytokine profiles in conjunctival allergy and inflammation. |
Q36238562 | Effects of Exposure to Ozone on the Ocular Surface in an Experimental Model of Allergic Conjunctivitis |
Q35590137 | Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis |
Q33232896 | Expression of beta defensins in ocular surface tissue of experimentally developed allergic conjunctivitis mouse model |
Q81516257 | Hypersensitivity responses and contact lens wear |
Q35762001 | Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice |
Q78693619 | MHC matching improves corneal allograft survival in mice with Th2-immune bias |
Q37016912 | Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa |
Q34529798 | New twists to an old story: novel concepts in the pathogenesis of allergic eye disease |
Q28184311 | Ocular allergy: implications for the clinical immunologist |
Q40265910 | Pathophysiology of atopic blepharokeratoconjunctivitis |
Q34036193 | Perennial allergic rhinitis and keratoconjunctivitis |
Q48016669 | Preliminary findings in corneal allograft rejection in patients with keratoconus |
Q35917624 | Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease |
Q36466392 | Silicone hydrogel contact lenses and the ocular surface. |
Q77999504 | Similar T helper Th2-like cytokine mRNA expression in vernal keratoconjunctivitis regardless of atopic constitution |
Q38238831 | T helper subsets in allergic eye disease |
Q35147322 | T-cell characterization in chronic allergic eye disease |
Q73094358 | Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis |
Q82831422 | Th1- and Th2-type cytokines in chronic ocular allergy |
Q41909205 | The anatomical and functional relationship between allergic conjunctivitis and allergic rhinitis |
Q35145988 | The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation |
Q82619639 | The possible involvement of nasal allergy in allergic keratoconjunctivitis |
Q33704295 | The role of allergen-specific T cells in the allergic immune response: relevance to allergy vaccination |
Q43709819 | Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses |
Q83580592 | Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis |
Q24670344 | Topical ciclosporin in the treatment of ocular surface disorders |
Q24198163 | Topical treatments for vernal keratoconjunctivitis |
Q28345365 | Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis |
Q87670900 | Vernal keratoconjunctivitis |
Q34674419 | Vernal keratoconjunctivitis: pathogenesis and treatment |
Q41985044 | Vitiligo in association with vernal keratoconjunctivitis |
Q79359962 | [Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system] |
Q81606847 | [Ocular allergies] |
Search more.